Ashvin Chhabra is President and Chief Investment Officer of Euclidean Capital, the New York family office for James H. See contact routes.
Ashvin Chhabra is President and Chief Investment Officer of Euclidean Capital, the New York family office for James H. Simons and Marilyn H. Simons, and he joined the firm in 2015 after senior investment roles at Merrill Lynch Wealth Management and the Institute for Advanced Study. Public descriptions of Euclidean say the office invests across public markets and private companies, with a notable emphasis on biotech and some later-stage private technology and life-sciences deals. Sources do not verify a standard check size or clear lead-versus-follow pattern for Chhabra. Named portfolio companies linked to Euclidean include Alector, PMV Pharmaceuticals, RAPT Therapeutics, Codagenix, ASAPP, Dascena, Ripple Foods, and FundGuard. Chhabra is also known as the author of The Aspirational Investor and as a proponent of goals-based wealth management.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in New York when building a target list.
Investors like Ashvin Chhabra · Full investor directory · Investor access · Company funding database